HCV Treatment Initiation in Patients with Chronic Kidney Disease: Results from ERCHIVES

BACKGROUND: Newer directing antiviral agents against HCV (DAAs) are safe and efficacious in persons with chronic kidney disease (CKD). Whether availability of these newer DAAs has resulted in more persons with CKD initiating HCV treatment remains unknown. METHODS: We identified HCV+ persons in ERCHI...

Descripción completa

Detalles Bibliográficos
Autores principales: Butt, Adeel, Ren, Yanjie, Puenpatom, Amy, Arduino, Jean Marie, Kumar, Ritesh, Abou-Samra, Abdul-Badi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632023/
http://dx.doi.org/10.1093/ofid/ofx163.384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632023/
http://dx.doi.org/10.1093/ofid/ofx163.384

Ejemplares similares